anti-Klebsiella pneumoniae phage (PHAXIAM Therapeutics)

N/A

Report date: 2025/06/11 11:24:24

Base Information

Drug Nameanti-Klebsiella pneumoniae phage (PHAXIAM Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Bacteriophages
Mechanisms of ActionAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhaxiam Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesPhaxiam Therapeutics SA
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionUrinary Tract InfectionsRespiratory Tract Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A